Virtu Financial’s Kiniksa Pharmaceuticals KNSA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$293K Sell
3,928
-601
-13% -$44.2K 0.01% 792
2026
Q2
$290K Buy
+4,529
New +$235K 0.01% 746
2026
Q1
– Sell
-6,466
Closed -$267K – 1992
2025
Q4
$267K Buy
+6,466
New +$259K 0.01% 899

Other funds holding KNSA

Virtu Financial's KNSA Position: Q3 2026 in Review

Virtu Financial reduced its Kiniksa Pharmaceuticals (KNSA) stake by 13% in Q3 2026, selling an estimated $44.2K and leaving 3,928 shares worth $293K. The position accounts for 0.01% of the portfolio, ranked #792.

Virtu Financial first reported a position in KNSA in Q4 2025 and has held it in 3 quarters since. 305 funds tracked by Wall St. Rank hold KNSA as of Q3 2026.

  • Virtu Financial held 3,928 shares of Kiniksa Pharmaceuticals worth $293K as of Q3 2026.
  • Virtu Financial sold 601 Kiniksa Pharmaceuticals shares in Q3 2026, an estimated $44.2K.
  • Kiniksa Pharmaceuticals made up 0.01% of Virtu Financial's portfolio in Q3 2026, its #792 holding.
  • Virtu Financial first reported a position in Kiniksa Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • 305 funds tracked by Wall St. Rank held Kiniksa Pharmaceuticals as of Q3 2026.

Based on Virtu Financial's 13F filing for Q3 2026, filed 17 Nov 2026.